Cargando…

The association of blood angioregulatory microRNA levels with circulating endothelial cells and angiogenic proteins in patients receiving dacarbazine and interferon

BACKGROUND: Blood biomarkers are needed to monitor anti-angiogenic treatments for cancer. The association of blood levels of microRNAs (miRs) implicated in angiogenesis with circulating endothelial cells (CEC) and with angiogenic proteins was examined in patients administered drugs with anti-angioge...

Descripción completa

Detalles Bibliográficos
Autores principales:	Triozzi, Pierre L, Achberger, Susan, Aldrich, Wayne, Singh, Arun D, Grane, Ronald, Borden, Ernest C
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2012
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3573971/ https://www.ncbi.nlm.nih.gov/pubmed/23217102 http://dx.doi.org/10.1186/1479-5876-10-241

Ejemplares similares

Angioregulatory microRNAs in Colorectal Cancer
por: Soheilifar, Mohammad Hasan, et al.
Publicado: (2019)

Association of tumor and plasma microRNA expression with tumor monosomy-3 in patients with uveal melanoma
por: Triozzi, Pierre L., et al.
Publicado: (2016)

Angioregulatory microRNAs in breast cancer: Molecular mechanistic basis and implications for therapeutic strategies
por: Soheilifar, Mohammad Hasan, et al.
Publicado: (2021)

Meta-Analysis of the Safety and Efficacy of Interferon Combined With Dacarbazine Versus Dacarbazine Alone in Cutaneous Malignant Melanoma
por: Xin, Yong, et al.
Publicado: (2016)

A randomized phase III study comparing dacarbazine, BCNU, cisplatin and tamoxifen with dacarbazine and interferon in advanced melanoma
por: Middleton, M R, et al.
Publicado: (2000)

Phase III randomized study of fotemustine and dacarbazine versus dacarbazine with or without interferon-α in advanced malignant melanoma
por: Daponte, Antonio, et al.
Publicado: (2013)

Basic Fibroblast Growth Factor Contributes to a Shift in the Angioregulatory Activity of Retinal Glial (Müller) Cells
por: Yafai, Yousef, et al.
Publicado: (2013)

Enrichment of circulating melanoma cells (CMCs) using negative selection from patients with metastatic melanoma
por: Joshi, Powrnima, et al.
Publicado: (2014)

In Vitro Characterization of Valproic Acid, ATRA, and Cytarabine Used for Disease-Stabilization in Human Acute Myeloid Leukemia: Antiproliferative Effects of Drugs on Endothelial and Osteoblastic Cells and Altered Release of Angioregulatory Mediators by Endothelial Cells
por: Kvestad, Hilde, et al.
Publicado: (2014)

Phosphatase inhibitor, sodium stibogluconate, in combination with interferon (IFN) alpha 2b: phase I trials to identify pharmacodynamic and clinical effects
por: Yi, Taolin, et al.
Publicado: (2011)

Inhibition and promotion of tumor growth with adeno-associated virus carcinoembryonic antigen vaccine and Toll like receptor agonists
por: Triozzi, Pierre L., et al.
Publicado: (2011)

Dacarbazine Combined Targeted Therapy versus Dacarbazine Alone in Patients with Malignant Melanoma: A Meta-Analysis
por: Jiang, Guan, et al.
Publicado: (2014)

Dacarbazine (DTIC) and human recombinant interferon alpha 2a (Roferon) in the treatment of disseminated malignant melanoma.
por: Mulder, N. H., et al.
Publicado: (1990)

Clinical and Immunological Outcomes in High-Risk Resected Melanoma Patients Receiving Peptide-Based Vaccination and Interferon Alpha, With or Without Dacarbazine Preconditioning: A Phase II Study
por: Urbani, Francesca, et al.
Publicado: (2020)

Dacarbazine (DTIC), human recombinant interferon alpha 2a (Roferon) and 5-fluorouracil for disseminated malignant melanoma.
por: Mulder, N. H., et al.
Publicado: (1992)

Anti-TNF-α treatment modulates SASP and SASP-related microRNAs in endothelial cells and in circulating angiogenic cells
por: Prattichizzo, Francesco, et al.
Publicado: (2016)

Q-TWiST analysis comparing ipilimumab/dacarbazine vs placebo/dacarbazine for patients with stage III/IV melanoma
por: Sherrill, B, et al.
Publicado: (2013)

Circulating ectosomes: Determination of angiogenic microRNAs in type 2 diabetes
por: Stępień, Ewa Ł., et al.
Publicado: (2018)

Circulating senescent angiogenic T cells are linked with endothelial dysfunction and systemic inflammation in hypertension
por: Zhang, Gaoxing, et al.
Publicado: (2021)

Chemoimmunotherapy with bleomycin, vincristine, lomustine, dacarbazine (BOLD) plus interferon alpha for metastatic melanoma: a multicentre phase II study.
por: Punt, C. J., et al.
Publicado: (1997)

Treatment of metastatic malignant melanoma with dacarbazine, vindesine and cisplatin.
por: Pectasides, D., et al.
Publicado: (1989)

Survival with dacarbazine and fotemustine in newly diagnosed glioblastoma multiforme
por: Fazeny-Dörner, B, et al.
Publicado: (2003)

Dacarbazine mediates antimelanoma effects via NK cells
por: Hervieu, Alice, et al.
Publicado: (2013)

Evaluation of protective effect of amifostine on dacarbazine induced genotoxicity
por: Etebari, M., et al.
Publicado: (2015)

Dacarbazine nanoparticle topical delivery system for the treatment of melanoma
por: Hafeez, Abdul, et al.
Publicado: (2017)

Post first-line dacarbazine or temozolomide in neuroendocrine carcinoma
por: Couronne, Thomas, et al.
Publicado: (2020)

Dacarbazine/doxorubicin/vinblastine: Lack of efficacy: case report
Publicado: (2022)

Insulin Resistance Impairs Circulating Angiogenic Progenitor Cell Function and Delays Endothelial Regeneration
por: Kahn, Matthew B., et al.
Publicado: (2011)

The angiogenic gene profile of circulating endothelial progenitor cells from ischemic stroke patients
por: Navarro-Sobrino, Míriam, et al.
Publicado: (2013)

Increase of Circulating Endothelial Progenitor Cells and Released Angiogenic Factors in Children with Moyamoya Arteriopathy
por: Gorla, Gemma, et al.
Publicado: (2023)

Baseline platelet counts and derived inflammatory biomarkers: prognostic relevance in metastatic melanoma patients receiving Endostar plus dacarbazine and cisplatin
por: Yang, Lingge, et al.
Publicado: (2019)

Efficacy of ifosfamide, dacarbazine, doxorubicin and cisplatin in human sarcoma xenografts.
por: Budach, W., et al.
Publicado: (1994)

Synthesis and Molecular-cellular Mechanistic Study of Pyridine Derivative of Dacarbazine
por: Amirmostofian, Marzieh, et al.
Publicado: (2013)

Dacarbazine depletes the ovarian reserve in mice and depletion is enhanced with age
por: Winship, Amy L., et al.
Publicado: (2018)

Synthesis, Spectroscopic, and Theoretical Study of Copper and Cobalt Complexes with Dacarbazine
por: Świderski, Grzegorz, et al.
Publicado: (2021)

MicroRNA-153-3p sensitizes melanoma cells to dacarbazine by suppressing ATG5-mediated autophagy and apoptosis
por: Hou, Shaowei, et al.
Publicado: (2020)

Circulating endothelial cells and angiogenic serum factors during neoadjuvant chemotherapy of primary breast cancer
por: Fürstenberger, G, et al.
Publicado: (2006)

Endothelial cell-derived pentraxin 3 limits the vasoreparative therapeutic potential of circulating angiogenic cells
por: O’Neill, Christina L., et al.
Publicado: (2016)

Circulating angiogenic stem cells in type 2 diabetes are associated with glycemic control and endothelial dysfunction
por: Zafar, Nagma, et al.
Publicado: (2018)

Effect of Smoking on Circulating Angiogenic Factors in High Risk Pregnancies
por: Jeyabalan, Arun, et al.
Publicado: (2010)

Cannot write session to /tmp/vufind_sessions/sess_2trljtr75hkchrhu9bm7hbq9s3